Investigation of Severe Hypoglycemia Risk Among Patients with Diabetes Treated with Ultra-Rapid Lispro in Japan
This study did not show a statistically significant increase in the incidence and risk of the first severe hypoglycemia event requiring a hospital visit in real-world URLi-treated patients in Japan, compared with a PS-matched cohort of other RAIA-treated patients.
Authors
- Satoshi Osaga (ORCID: https://orcid.org/0000-0003-4459-2469)
- Shoko Mizuno
- Rina Chin (ORCID: https://orcid.org/0000-0001-5578-7814)
- Machiko Minatoya (ORCID: https://orcid.org/0000-0002-1306-3073)
- Makoto Imori
Institutions
- Eli Lilly (Japan) (JP)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1007/s12325-024-03050-1
- Citations
- 2
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.72
Funders
- Eli Lilly and Company
- Eli Lilly Japan